The Brain’s Pain Map: What Brain Scans Can Show

The colored patches on a brain image can look like an answer. Understanding how that image was made tells you what it can actually answer.

If you have had pain that a scan could not explain, an image promising to “show pain in the brain” may sound welcome. It might also raise a troubling question: would you have to produce that image to be believed?

Karen Davis’s webinar, Charting the Brain’s Pain Map: Why Mine Is Different Than Yours, offers a useful starting point. She explains how researchers study activity, structure, and connections. Our commentary focuses on how to read those findings without asking a scan to speak for the person.

Several systems contribute to pain

Davis draws attention to the sensorimotor, salience, and default mode networks, along with pathways involved in pain modulation. These names describe groups of interacting brain regions. Their roles extend beyond pain, and their activity changes with the task and the person.

Watch the network explanation around 26:58. The value of the map is that it makes relationships visible. It does not divide people into a “sensory pain” group and an “emotional pain” group.

How does fMRI turn brain activity into a map?

Functional MRI often uses a signal called BOLD, short for blood oxygenation level dependent. It detects changes related to blood oxygenation that accompany neural activity. It does not directly record neurons firing. The blood response also unfolds more slowly than the neural events it helps researchers study. UC San Diego’s Center for Functional MRI explains the method.

Davis makes this distinction especially clearly around 23:05. Before interpreting a colored patch, ask what was compared, who took part, and what the color scale means. A group average and an individual result answer different questions.

Functional connectivity asks whether signals in different regions fluctuate together. That statistical relationship does not, by itself, establish a direct physical connection or show which region caused the other to change. Structural imaging addresses different questions about tissue and pathways.

Is the “pain matrix” a pain detector?

The term pain matrix has been used for regions that often respond during painful stimulation. The name can imply more specificity than the evidence supports. A multisensory fMRI study by Mouraux and colleagues found that salient, non-nociceptive stimuli could also recruit this network. Seeing these regions respond is therefore insufficient to establish pain on its own.

That finding does not make imaging useless. It changes the question from “Did a region light up?” to “How well does this particular pattern distinguish the experience we are trying to study?” A convincing answer needs testing beyond the data used to develop it.

Can a brain scan prove or disprove chronic pain?

No single scan accurately and completely measures another person’s pain. Imaging can still help clinicians investigate structural causes when appropriate. A test that does not explain the symptoms leaves a question open; it does not establish that the symptoms are invented. See the NIH overview of pain assessment.

The 2017 IASP task-force recommendations, led by Davis, set out evidence standards for using brain imaging in clinical or legal decisions. A research association is not enough to justify deciding whose report counts.

Research has moved forward since the webinar. A 2025 study of a corticospinal pain-sensitivity signature combined brain and spinal-cord imaging across eight datasets. Its clinical samples included 22 people with diabetes-related chronic pain and 24 with zoster-associated pain. Those findings support further investigation. They do not establish a universal test for every person or condition.

What this means for Cindra

For the companion we are building, the most useful “map” would begin with what someone chooses to tell us: where pain interrupts the day, what they tried, and what they want help discussing. We should label that record as self-reported information. Calling it a brain map would imply measurements we have not made.

Three product requirements follow from our reading of the research:

• Keep the person’s account visible. A summary should preserve uncertainty and allow corrections. It should never use a wearable reading or chat pattern to overrule reported pain.
• Explain where every visual comes from. Educational diagrams, reported symptoms, and measured biological data need clear labels. A decorative brain graphic should not suggest a diagnosis.
• Keep clinical decisions with qualified care. Cindra should not select treatment from an inferred brain type or reassure someone that new symptoms are harmless.

These are proposed requirements, not verified product capabilities or clinical results. The companion article on pain threshold and tolerance explores what individual differences mean for everyday support.

About the video and this commentary

Work Wellness Institute published the recording on December 13, 2016. We read the complete English auto-generated captions, including the Q&A, and inspected selected slides. We did not review the entire audiovisual recording. Near 50:45, Davis explicitly describes treatment-prediction work as experimental and based on relatively small groups. We retain that distinction and check it against later research rather than present a 2016 forecast as an available Cindra feature.

Educational commentary and proposed product requirements. Sources checked October 27, 2026. This article has not undergone clinical review and does not provide an individualized care plan. Cindra requires product-specific evaluation before clinical benefit can be claimed.